curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

Sacral Neuromodulation in Patients With Double Incontinence

by palligoelme@gmail.com | Oct 8, 2025 | Clinical Trials

​ Conditions: Double Incontinence; Faecal Incontinence; Urinary Incontinence Interventions: Procedure: Sacral neurostimulation Sponsors: University Hospital Ostrava Not yet recruiting Conditions: Double Incontinence; Faecal Incontinence; Urinary Incontinence...

Immersive Virtual Reality vs Treadmill Exercise Project

by palligoelme@gmail.com | Oct 8, 2025 | Clinical Trials

​ Conditions: Control; Virtual Reality Physical Activity; Treadmill Interventions: Behavioral: VRPA; Behavioral: Treadmill; Behavioral: Control Sponsors: Rowan University Recruiting Conditions: Control; Virtual Reality Physical Activity; Treadmill Interventions:...

Acquired Dyslexia Modeling and Treatment

by palligoelme@gmail.com | Oct 7, 2025 | Clinical Trials

​ Conditions: Stroke; Dyslexia, Acquired Interventions: Behavioral: Phono-Motor Therapy; Behavioral: Semantic Feature Analysis Sponsors: Rutgers, The State University of New Jersey; National Institute on Deafness and Other Communication Disorders (NIDCD) Not yet...

Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area – Post-Market Clinical Follow-up

by palligoelme@gmail.com | Oct 7, 2025 | Clinical Trials

​ Conditions: Bradycardia; Atrioventricular Block; Sinus Node Dysfunction; Bundle-Branch Block Interventions: Device: Pacemaker lead Sponsors: Boston Scientific Corporation Not yet recruiting Conditions: Bradycardia; Atrioventricular Block; Sinus Node Dysfunction;...

Open-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy

by palligoelme@gmail.com | Oct 7, 2025 | Clinical Trials

​ Conditions: Duchenne Muscular Dystrophy Interventions: Drug: WVE-N531 Sponsors: Wave Life Sciences Ltd. Not yet recruiting Conditions: Duchenne Muscular Dystrophy Interventions: Drug: WVE-N531 Sponsors: Wave Life Sciences Ltd. Not yet...

Pre-habilitation Within ERAS Protocol for Gynecologic Oncology Surgery: The Pre_ERAS Study

by palligoelme@gmail.com | Oct 7, 2025 | Clinical Trials

​ Conditions: ERAS; Compliance; Quality of Life (QOL); Excercise; Immunonutrition; Post Operative Pain; Laparotomy Patients; Surgical Complication; Gynaecological Malignancies; Gynaecologic Cancer; Gynaecological Oncology Interventions: Dietary Supplement: Ocoxin;...
« Older Entries
Next Entries »

Recent Posts

  • Pulse Wave vs. Saline Contrast EIT for Pulmonary Perfusion in ARDS
  • The EYERISING Study
  • Comparing the Extent to Which Apremilast is Made Available in the Body After Administration as an Extended-release or Immediate-release Formulation
  • Observational Analytical Validation Study of the Replior ScratchSense
  • The Immunobiological Mechanisms of Depression in Perimenopause

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®